DUGGAN ROBERT W 内部人交易：近期 SEC Form 4 交易
过去 18 个月，DUGGAN ROBERT W（CIK 1055919）在 2 家公司共报告 13 笔 SEC Form 4 内部人交易（最近一笔 2026-06-12）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-06-12 | Summit Therapeutics Inc. (SMMT) | Co-Chief Executive Officer | 买入 | 3.8M | $50.0M |
| 2026-06-04 | Summit Therapeutics Inc. (SMMT) | Co-Chief Executive Officer | 买入 | 100,000 | $1.5M |
| 2026-05-15 | PULSE BIOSCIENCES, INC. (PLSE) | 董事 | 买入 | 660,233 | $13.0M |
| 2026-05-11 | PULSE BIOSCIENCES, INC. (PLSE) | 董事 | 买入 | 660,233 | $13.0M |
| 2025-10-23 | Summit Therapeutics Inc. (SMMT) | Co-Chief Executive Officer | 买入 | 14.0M | $262.0M |
| 2025-10-23 | Summit Therapeutics Inc. (SMMT) | Co-Chief Executive Officer | 买入 | 266,808 | $5.0M |
| 2025-10-23 | Summit Therapeutics Inc. (SMMT) | Co-Chief Executive Officer | 买入 | 26,680 | $499,983 |
| 2025-09-12 | PULSE BIOSCIENCES, INC. (PLSE) | 董事 | 买入 | 34,659 | $508,101 |
| 2025-09-12 | PULSE BIOSCIENCES, INC. (PLSE) | 董事 | 买入 | 12,800 | $189,056 |
| 2025-09-12 | PULSE BIOSCIENCES, INC. (PLSE) | 董事 | 买入 | 145,140 | $2.1M |
| 2025-09-11 | Summit Therapeutics Inc. (SMMT) | Co-Chief Executive Officer | 买入 | 333,394 | $5.9M |
| 2025-09-11 | Summit Therapeutics Inc. (SMMT) | Co-Chief Executive Officer | 买入 | 5,000 | $90,350 |
| 2025-06-02 | Summit Therapeutics Inc. (SMMT) | Co-Chief Executive Officer | 买入 | 74,545 | $196,799 |
来源：SEC Form 4 申报文件 · 截至 2026-06-12